Advertisement
Singapore markets open in 8 hours 11 minutes
  • Straits Times Index

    3,293.13
    +20.41 (+0.62%)
     
  • S&P 500

    5,049.06
    -21.49 (-0.42%)
     
  • Dow

    38,327.50
    -176.19 (-0.46%)
     
  • Nasdaq

    15,647.32
    -49.32 (-0.31%)
     
  • Bitcoin USD

    64,688.71
    -2,078.36 (-3.11%)
     
  • CMC Crypto 200

    1,392.82
    -31.28 (-2.20%)
     
  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     
  • Gold

    2,339.20
    -2.90 (-0.12%)
     
  • Crude Oil

    82.61
    -0.75 (-0.90%)
     
  • 10-Yr Bond

    4.6480
    +0.0500 (+1.09%)
     
  • Nikkei

    38,460.08
    +907.92 (+2.42%)
     
  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     
  • FTSE Bursa Malaysia

    1,571.48
    +9.84 (+0.63%)
     
  • Jakarta Composite Index

    7,174.53
    +63.72 (+0.90%)
     
  • PSE Index

    6,572.75
    +65.95 (+1.01%)
     

Why Viking Therapeutics Stock Is Buckling Today

Why Viking Therapeutics Stock Is Buckling Today

Shares of the clinical-stage metabolic disorder specialist Viking Therapeutics (NASDAQ: VKTX) were down by 6.45% on moderate volume as of 1:42 p.m. ET Thursday afternoon. Small- and mid-cap biotech stocks are under pressure today following the Federal Trade Commission's (FTC) decision to sue over the proposed merger between Amgen and Horizon Therapeutics earlier this week. Before investors get too concerned, however, it's important to understand what's actually driving this takeover speculation.